secwatch.observer — SEC 8-K summary
======================================

Issuer:     BiomX Inc. (PHGE)
CIK:        0001739174
Form:       8-K
Filed at:   2024-07-29T23:59:59+00:00
Accession:  0001013762-24-001812
Event type: regulatory
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

BiomX gets NYSE American approval of compliance plan; deadline extended to Nov 2025
--------------------------------------------------------------------------------

- NYSE American accepted BiomX's plan to regain compliance with continued listing standards under Sections 1003(a)(i), (ii), (iii).
- Company has until November 23, 2025 to meet listing requirements; stock continues trading on NYSE American under PHGE.
- Previously disclosed deficiency in May 2024; plan acceptance avoids immediate delisting but periodic reviews apply.
- If compliance not achieved by Nov 2025 or insufficient progress, NYSE American may initiate delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739174/000101376224001812/0001013762-24-001812-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739174/000101376224001812/ea0210175-8k_biomx.htm
  HTML page:      https://secwatch.observer/filing/0001013762-24-001812

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer